April 16, 2025 1:05 pm EDT

Sydney, Australia – 16 April 2025

Today Organon ANZ is proudly launching the Path to Parenthood – a dedicated platform providing fertility information, support and personal experiences to support those undertaking the journey to start or grow their families, using In Vitro Fertilisation (IVF).

Path to Parenthood website offers clear, practical information about the fertility options available, when to seek support and what to expect from that support. Importantly, it shares stories from couples and individual’s unique experiences, providing learnings and guidance to help others as they undertake their own unique journey.

For Courtney, participating in this initiative was critical for her and her husband Emmett, to raise awareness of the uniqueness of each person’s experience of IVF.

“IVF looks different to everyone. It can be an extremely isolating and long process, and when you’re going through it, it can be hard to find others who understand it’s complexities. Being able to have resources like Path to Parenthood to navigate through in the way that works best for you is essential when it comes to managing the overwhelming experience of IVF”, said Courtney.

Infertility effects 16% or 1 in 6 Australians.¹ For these people, there is an urgent need to provide access to the latest information in a clear and concise manner, alongside the highest quality care.

Organon was founded with the commitment to listen to women and address their unique health needs. “We know that the fertility journey rarely follows a straight path, and everyone’s experience is completely unique”, said Mr Bilal Somra, Managing Director, Organon ANZ.

“With accessible information and personal stories providing a sense of community, the Path to Parenthood platform is one of our new ways to support those experiencing the twists and turns of fertility”, continued Mr Somra.

To learn more about this platform, visit www.pathtoparenthood.com.au.

You can access further information about Organon ANZ and connect with us on LinkedIn at @OrganonANZ.

About Organon

Organon is a global healthcare company with a focus on improving the health of women throughout their lives. Organon has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the women’s health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in innovation and future growth opportunities in women’s health. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialise their products by leveraging its scale and presence in fast growing international markets.

Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,300 employees with headquarters located in Jersey City, New Jersey.

Copyright 2025 Organon group of companies. All rights reserved. Organon ANZ, Level 5, 66 King St Sydney, NSW 2000. Date of Preparation: March 2025. AU-NON-110267.

References

1. Family planning NSW. Infertility. Available at: https://www.fpnsw.org.au/factsheets/individuals/fertility-and-infertility/infertility. Accessed January 2025.